Ginkgo Flavonol Glycosides or Ginkgolides Tend to Differentially Protect Myocardial or Cerebral Ischemia-Reperfusion Injury via Regulation of TWEAK-Fn14 Signaling in Heart and Brain

• Autores principales: Guangxu Xiao (Autor), Ming Lyu (Autor), Yule Wang (Autor), Shuang He (Autor), Xinyan Liu (Autor), Jingyu Ni (Autor), Lan Li (Autor), Guanwei Fan (Autor), Jihong Han (Autor), Xiumei Gao (Autor), Xiaoying Wang (Autor), Yan Zhu (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2019-07-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Shuxuening injection (SXNI), one of the pharmaceutical preparations of Ginkgo biloba extract, has significant effects on both ischemic stroke and heart diseases from bench to bedside. Its major active ingredients are ginkgo flavonol glycosides (GFGs) and ginkgolides (GGs). We have previously reported...